2023-08-05 18:34
Achilles Therapeutics (NASDAQ:ACHL) Announces Quarterly Earnings Results, Misses Expectations By $0.02 EPS
Achilles Therapeutics ( NASDAQ:ACHL – Get Free Report ) announced its quarterly earnings data on Friday. The company reported ($0.42) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.40) by ($0.02), Yahoo Finance reports. Achilles Therapeutics Price Performance NASDAQ ACHL remained flat at $1.00 during trading hours on Friday. 40,942 shares of the company traded hands, compared to its average volume of 113,331. Achilles Therapeutics has a one year low of $0.

https://www.dailypolitical.com/2023/08/05/achilles-therapeutics-nasdaqachl-announces-quarterly-earnings-results-misses-expectations-by-0-02-eps.html

#dailypolitical